Report Detail

Food & Beverages Global Human Milk Oligosaccharides (HMO) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM2880319
  • |
  • 17 April, 2023
  • |
  • Global
  • |
  • 103 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Food & Beverages

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
According to our (Global Info Research) latest study, the global Human Milk Oligosaccharides (HMO) market size was valued at USD 396 million in 2022 and is forecast to a readjusted size of USD 1015.7 million by 2029 with a CAGR of 14.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core human milk oligosaccharides (HMO) manufacturers include Abbott, Glycom etc.The top 2 companies hold a share about 70%. North America is the largest market, with a share about 45%, followed by Europe and China with the share about 32% and 10%.In terms of product, 2'-FL & 3-FL is the largest segment, with a share over 95%. And in terms of application, the largest application is infant formula.
This report is a detailed and comprehensive analysis for global Human Milk Oligosaccharides (HMO) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Human Milk Oligosaccharides (HMO) market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (USD/Kg), 2018-2029
Global Human Milk Oligosaccharides (HMO) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (USD/Kg), 2018-2029
Global Human Milk Oligosaccharides (HMO) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (USD/Kg), 2018-2029
Global Human Milk Oligosaccharides (HMO) market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (USD/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Milk Oligosaccharides (HMO)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Milk Oligosaccharides (HMO) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein) and ZuChem and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Human Milk Oligosaccharides (HMO) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
2'-FL & 3-FL
Sialyllactose
LNT & LNnT
Market segment by Application
Infant Formula
Functional Food & Beverages
Food/Medical Supplements
Others
Major players covered
Abbott
Inbiose
Glycom
Chr. Hansen (Jennewein)
ZuChem
Glycom
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Milk Oligosaccharides (HMO) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Milk Oligosaccharides (HMO), with price, sales, revenue and global market share of Human Milk Oligosaccharides (HMO) from 2018 to 2023.
Chapter 3, the Human Milk Oligosaccharides (HMO) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Milk Oligosaccharides (HMO) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Human Milk Oligosaccharides (HMO) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Milk Oligosaccharides (HMO).
Chapter 14 and 15, to describe Human Milk Oligosaccharides (HMO) sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Human Milk Oligosaccharides (HMO)
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Human Milk Oligosaccharides (HMO) Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 2'-FL & 3-FL
    • 1.3.3 Sialyllactose
    • 1.3.4 LNT & LNnT
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Human Milk Oligosaccharides (HMO) Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Infant Formula
    • 1.4.3 Functional Food & Beverages
    • 1.4.4 Food/Medical Supplements
    • 1.4.5 Others
  • 1.5 Global Human Milk Oligosaccharides (HMO) Market Size & Forecast
    • 1.5.1 Global Human Milk Oligosaccharides (HMO) Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Human Milk Oligosaccharides (HMO) Sales Quantity (2018-2029)
    • 1.5.3 Global Human Milk Oligosaccharides (HMO) Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Abbott
    • 2.1.1 Abbott Details
    • 2.1.2 Abbott Major Business
    • 2.1.3 Abbott Human Milk Oligosaccharides (HMO) Product and Services
    • 2.1.4 Abbott Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Abbott Recent Developments/Updates
  • 2.2 Inbiose
    • 2.2.1 Inbiose Details
    • 2.2.2 Inbiose Major Business
    • 2.2.3 Inbiose Human Milk Oligosaccharides (HMO) Product and Services
    • 2.2.4 Inbiose Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Inbiose Recent Developments/Updates
  • 2.3 Glycom
    • 2.3.1 Glycom Details
    • 2.3.2 Glycom Major Business
    • 2.3.3 Glycom Human Milk Oligosaccharides (HMO) Product and Services
    • 2.3.4 Glycom Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Glycom Recent Developments/Updates
  • 2.4 Chr. Hansen (Jennewein)
    • 2.4.1 Chr. Hansen (Jennewein) Details
    • 2.4.2 Chr. Hansen (Jennewein) Major Business
    • 2.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product and Services
    • 2.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Chr. Hansen (Jennewein) Recent Developments/Updates
  • 2.5 ZuChem
    • 2.5.1 ZuChem Details
    • 2.5.2 ZuChem Major Business
    • 2.5.3 ZuChem Human Milk Oligosaccharides (HMO) Product and Services
    • 2.5.4 ZuChem Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 ZuChem Recent Developments/Updates
  • 2.6 Glycom
    • 2.6.1 Glycom Details
    • 2.6.2 Glycom Major Business
    • 2.6.3 Glycom Human Milk Oligosaccharides (HMO) Product and Services
    • 2.6.4 Glycom Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Glycom Recent Developments/Updates

3 Competitive Environment: Human Milk Oligosaccharides (HMO) by Manufacturer

  • 3.1 Global Human Milk Oligosaccharides (HMO) Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturer (2018-2023)
  • 3.3 Global Human Milk Oligosaccharides (HMO) Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Human Milk Oligosaccharides (HMO) by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Human Milk Oligosaccharides (HMO) Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Human Milk Oligosaccharides (HMO) Manufacturer Market Share in 2022
  • 3.5 Human Milk Oligosaccharides (HMO) Market: Overall Company Footprint Analysis
    • 3.5.1 Human Milk Oligosaccharides (HMO) Market: Region Footprint
    • 3.5.2 Human Milk Oligosaccharides (HMO) Market: Company Product Type Footprint
    • 3.5.3 Human Milk Oligosaccharides (HMO) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Human Milk Oligosaccharides (HMO) Market Size by Region
    • 4.1.1 Global Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Human Milk Oligosaccharides (HMO) Consumption Value by Region (2018-2029)
    • 4.1.3 Global Human Milk Oligosaccharides (HMO) Average Price by Region (2018-2029)
  • 4.2 North America Human Milk Oligosaccharides (HMO) Consumption Value (2018-2029)
  • 4.3 Europe Human Milk Oligosaccharides (HMO) Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value (2018-2029)
  • 4.5 South America Human Milk Oligosaccharides (HMO) Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Human Milk Oligosaccharides (HMO) Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2018-2029)
  • 5.2 Global Human Milk Oligosaccharides (HMO) Consumption Value by Type (2018-2029)
  • 5.3 Global Human Milk Oligosaccharides (HMO) Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2018-2029)
  • 6.2 Global Human Milk Oligosaccharides (HMO) Consumption Value by Application (2018-2029)
  • 6.3 Global Human Milk Oligosaccharides (HMO) Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2018-2029)
  • 7.2 North America Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2018-2029)
  • 7.3 North America Human Milk Oligosaccharides (HMO) Market Size by Country
    • 7.3.1 North America Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Human Milk Oligosaccharides (HMO) Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2018-2029)
  • 8.2 Europe Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2018-2029)
  • 8.3 Europe Human Milk Oligosaccharides (HMO) Market Size by Country
    • 8.3.1 Europe Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Human Milk Oligosaccharides (HMO) Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size by Region
    • 9.3.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2018-2029)
  • 10.2 South America Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2018-2029)
  • 10.3 South America Human Milk Oligosaccharides (HMO) Market Size by Country
    • 10.3.1 South America Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Human Milk Oligosaccharides (HMO) Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Human Milk Oligosaccharides (HMO) Market Size by Country
    • 11.3.1 Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Human Milk Oligosaccharides (HMO) Market Drivers
  • 12.2 Human Milk Oligosaccharides (HMO) Market Restraints
  • 12.3 Human Milk Oligosaccharides (HMO) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Human Milk Oligosaccharides (HMO) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Human Milk Oligosaccharides (HMO)
  • 13.3 Human Milk Oligosaccharides (HMO) Production Process
  • 13.4 Human Milk Oligosaccharides (HMO) Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Human Milk Oligosaccharides (HMO) Typical Distributors
  • 14.3 Human Milk Oligosaccharides (HMO) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Human Milk Oligosaccharides (HMO) . Industry analysis & Market Report on Human Milk Oligosaccharides (HMO) is a syndicated market report, published as Global Human Milk Oligosaccharides (HMO) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Human Milk Oligosaccharides (HMO) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,777.04
    4,165.56
    5,554.08
    3,246.84
    4,870.26
    6,493.68
    535,084.80
    802,627.20
    1,070,169.60
    290,440.80
    435,661.20
    580,881.60
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report